• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Transmembrane protein 126A (TMEM126A), Truncated

ACP08490

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP08490 Target NameTMEM126A
Target SynonymsTMEM126A; Transmembrane protein 126AFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H061
Background Information
  • Uniprot Id

    Q9H061

  • Target Species

    Human

  • Target Name

    TMEM126A

  • Target Full Name

    Transmembrane protein 126A

  • Target Involvement

    Optic atrophy 7 with or without auditory neuropathy (OPA7)

  • Target Subcellular Location

    Mitochondrion inner membrane; Multi-pass membrane protein.

  • Target Protein Families

    TMEM126 family

  • Target Tissue Specificity

    Strongly expressed in brain, cerebellum, skeletal muscle, testis. High expression also found in fetal brain, fetal retinal pigmentary epithelium, and fetal retina. Highly expressed in retinal ganglion cells.

  • Target Synonyms

    TMEM126A; Transmembrane protein 126A

  • Target Background

    The protein encoded by this gene is a mitochondrial membrane protein of unknown function. Defects in this gene are a cause of optic atrophy type 7 (OPA7). Two transcript variants encoding different isoforms have been found for this gene.

Inquire Recombinant Human Transmembrane protein 126A (TMEM126A), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification